Save Us Chuck Woolery

ContraVir Continues to Win on More Positive HBV Updates

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) is watching its shares make a handy gain in Monday’s session after the company announced a positive development in its mid-stage Hepatitis B (HBV)...

Comments are closed.